Skip to main content
Clinical Trials/NCT03612115
NCT03612115CompletedNot Applicable

Investigation of the Effects of Neuromuscular Electrical Stimulation in Patients With Pulmonary Arterial Hypertension

Dokuz Eylul University1 site in 1 country31 target enrollmentStarted: September 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
31
Locations
1
Primary Endpoint
Isometric muscle strength

Study Overview

Brief Summary

This study aimed to investigate the effects of neuromuscular electrical stimulation on peripheral muscles and other physical and psychosocial variables in patients with pulmonary arterial hypertension. This study was designed as an assessor-blind randomized controlled trial. Thirty-one patients with pulmonary arterial hypertension will be recruited. The participants will randomly divided two parallel groups as treatment and control. For the treatment group, neuromuscular electrical stimulation will be applied to the bilateral deltoid and quadriceps femoris muscles with 50 Hz for 3 days/week, 8 weeks. Control group will not be received any additional treatment, just given healthy life recommendations such as walking. The participants will be assessed before and after the treatment by a blind assessor to the group allocation. The outcome measure will be assessments of the upper and lower limb muscle strength, respiratory muscle strength, muscle cross-sectional area and thickness, pulse wave velocity, exercise capacity, walking speed, functional mobility and balance performances, balance confidence, fatigue perceptions, physical activity level, activities of daily living and quality of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Elevated pulmonary artery pressures measured by right heart catheterization
  • •New York Heart Association class II or III
  • •Stabile Pulmonary Arterial Hypertension-specific pharmaceutical therapy for 3 months

Exclusion Criteria

  • •Orthopaedic problems
  • •Significant restrictive or obstructive pulmonary disease
  • •Acute cor pulmonale.

Arms & Interventions

Neuromuscular electrical stimulation intervention

Experimental

Neuromuscular electrical stimulation treatment

Intervention: Neuromuscular electrical stimulation (Device)

Control

No Intervention

No additional intervention

Outcomes

Primary Outcomes

Isometric muscle strength

Time Frame: Change from Baseline at 8 weeks

Isometric muscle strength for knee extensors

Secondary Outcomes

  • 4-m Gait Speed Test(Change from Baseline at 8 weeks)
  • Isometric muscle strength(Change from Baseline at 8 weeks)
  • Hand grip strength(Change from Baseline at 8 weeks)
  • Quadriceps femoris muscle thickness(Change from Baseline at 8 weeks)
  • Rectus femoris cross-sectional area(Change from Baseline at 8 weeks)
  • Pulse wave velocity(Change from Baseline at 8 weeks)
  • Six-Minute Walk Test(Change from Baseline at 8 weeks)
  • Six-Minute Pegboard and Ring Test(Change from Baseline at 8 weeks)
  • Sit-to-Stand Test(Change from Baseline at 8 weeks)
  • Timed-Up and Go Test(Change from Baseline at 8 weeks)
  • Activities-specific Balance Confidence Scale(Change from Baseline at 8 weeks)
  • Fatigue Impact Scale(Change from Baseline at 8 weeks)
  • International Physical Activity Questionnaire-Short Form(Change from Baseline at 8 weeks)
  • Milliken Activities of Daily Living Scale(Change from Baseline at 8 weeks)
  • Nottingham Health Profile(Change from Baseline at 8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Buse Ozcan Kahraman

Principal Investigator

Dokuz Eylul University

Study Sites (1)

Loading locations...

Similar Trials

Neuromuscular Electrical Stimulation in... | Clinical Trial